Skip to main content
Top
Published in: BMC Neurology 1/2022

Open Access 01-12-2022 | Multiple Sclerosis | Research

Epidemiology of familial multiple sclerosis in Iran: a national registry-based study

Authors: Zahra Salehi, Amir Almasi-Hashiani, Mohammad Ali Sahraian, Fereshteh Ashtari, Seyed Mohammad Baghbanian, Nazanin Razazian, Abdorreza Naser Moghadasi, Asghar Bayati, Amir Reza Azimi, Nahid Beladimoghadam, Mohammad Hossein Harirchian, Maryam Poursadeghfard, Samira Navardi, Reza Shirkoohi, Hora Heidari, Mehran Ghaffari, Sharareh Eskandarieh

Published in: BMC Neurology | Issue 1/2022

Login to get access

Abstract

Background

Admittedly, little is known about the epidemiological signatures of familial multiple sclerosis (FMS) in different geographical regions of Iran.

Objective

To determine the epidemiology and the risk of FMS incidence in several provinces of Iran with a different ethnic population including, Fars, Tehran, Isfahan (Persians), and Mazandaran (Mazanis), Kermanshah (Kurds), and Chaharmahal and Bakhtiari (Lors).

Methods

This cross-sectional registry-based study was performed on nationwide MS registry of Iran (NMSRI) data collected from 2018 to 2021. This system, registers baseline characteristics, clinical presentations and symptoms, diagnostic and treatments at regional and national levels.

Results

A total of 9200 patients including, 7003 (76.1%) female and 2197 (23.9%) male, were participated. About 19% of patients reported a family history of MS; the order from highest to lowest FMS prevalence was as follows: Fars (26.5%), Chaharmahal and Bakhtiari (21.1%), Tehran (20.5%), Isfahan (20.3%), Mazandaran (18.0%), and Kermanshah (12.5%). Of all FMS cases, 74.7% (1308 cases) were female and 25.3% (442 cases) were male. FMS occurrence was much more common in females than males (P-value = 0.001). Further, the mean age at onset was 30 years among FMS cases. A substantially higher probability of relapsing-remitting MS and secondary-progressive MS was found among FMS cases than sporadic MS (SMS) (P_value = 0.001). There was no significant difference in Expanded Disability Status Scale (EDSS) scores between FMS and SMS. The majority of FMS cases were observed among first-degree relatives, with the highest rate in siblings. There was a significant association between MS risk and positive familial history in both maternal and paternal aunt/uncle (P_value = 0.043 and P_value = 0.019, respectively). Multiple sclerosis occurrence among offspring of females was higher than males (P_value = 0.027).

Conclusions

In summary, our findings imply a noteworthy upward trend of FMS in Iran, even more than the global prevalence, which suggests a unique Atlas of FMS prevalence in this multi-ethnic population. Despite the highest rate of FMS within Persian and Lor ethnicities, no statistically significant difference was observed among the provinces.
Literature
1.
go back to reference Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, et al. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):459–80.CrossRef Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, et al. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):459–80.CrossRef
2.
go back to reference Dobson R, Giovannoni G. Multiple sclerosis–a review. Eur J Neurol. 2019;26(1):27–40.CrossRef Dobson R, Giovannoni G. Multiple sclerosis–a review. Eur J Neurol. 2019;26(1):27–40.CrossRef
3.
go back to reference Wallin MT, Culpepper WJ, Nichols E, Bhutta ZA, Gebrehiwot TT, Hay SI, et al. Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(3):269–85.CrossRef Wallin MT, Culpepper WJ, Nichols E, Bhutta ZA, Gebrehiwot TT, Hay SI, et al. Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(3):269–85.CrossRef
4.
go back to reference Lotti CBC, Oliveira ASB, Bichuetti DB, Castro I, Oliveira EML. Late onset multiple sclerosis: concerns in aging patients. Arq Neuropsiquiatr. 2017;75(7):451–6.CrossRef Lotti CBC, Oliveira ASB, Bichuetti DB, Castro I, Oliveira EML. Late onset multiple sclerosis: concerns in aging patients. Arq Neuropsiquiatr. 2017;75(7):451–6.CrossRef
5.
go back to reference Salehi Z, Almasi-Hashiani A, Sahraian MA, Eskandarieh S. Epidemiology of familial multiple sclerosis: a population-based study in Tehran during 1999–2018. Multiple Scleros Related Disord. 2020;43:102178.CrossRef Salehi Z, Almasi-Hashiani A, Sahraian MA, Eskandarieh S. Epidemiology of familial multiple sclerosis: a population-based study in Tehran during 1999–2018. Multiple Scleros Related Disord. 2020;43:102178.CrossRef
6.
go back to reference Kaymakamzade B, Kiliç AK, Kurne AT, Karabudak R. Progressive onset multiple sclerosis: demographic, clinical and laboratory characteristics of patients with and without relapses in the course. Arch Neuropsych. 2019;56(1):23. Kaymakamzade B, Kiliç AK, Kurne AT, Karabudak R. Progressive onset multiple sclerosis: demographic, clinical and laboratory characteristics of patients with and without relapses in the course. Arch Neuropsych. 2019;56(1):23.
7.
go back to reference Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15(9):545–58.CrossRef Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15(9):545–58.CrossRef
8.
go back to reference Wang Z, Sadovnick AD, Traboulsee AL, Ross JP, Bernales CQ, Encarnacion M, et al. Nuclear receptor NR1H3 in familial multiple sclerosis. Neuron. 2016;90(5):948–54.CrossRef Wang Z, Sadovnick AD, Traboulsee AL, Ross JP, Bernales CQ, Encarnacion M, et al. Nuclear receptor NR1H3 in familial multiple sclerosis. Neuron. 2016;90(5):948–54.CrossRef
9.
go back to reference Harding KE, Robertson NP. New rare genetic variants in multiple sclerosis. J Neurol. 2019;266(1):278–80.CrossRef Harding KE, Robertson NP. New rare genetic variants in multiple sclerosis. J Neurol. 2019;266(1):278–80.CrossRef
10.
go back to reference Curtius F. Multiple sklerose und erbanlage: Thieme; 1933;59(8):279–81. Curtius F. Multiple sklerose und erbanlage: Thieme; 1933;59(8):279–81.
11.
go back to reference Ehtesham N, Rafie MZ, Mosallaei M. The global prevalence of familial multiple sclerosis: an updated systematic review and meta-analysis. 2021;28;21(1):246. Ehtesham N, Rafie MZ, Mosallaei M. The global prevalence of familial multiple sclerosis: an updated systematic review and meta-analysis. 2021;28;21(1):246.
12.
go back to reference AlJumah M, Otaibi HA, Al Towaijri G, Hassan A, Kareem A, Kalakatawi M, et al. Familial aggregation of multiple sclerosis: results from the national registry of the disease in Saudi Arabia. Multiple Sclerosis J–Exper Transl Clin. 2020;6(4):2055217320960499.CrossRef AlJumah M, Otaibi HA, Al Towaijri G, Hassan A, Kareem A, Kalakatawi M, et al. Familial aggregation of multiple sclerosis: results from the national registry of the disease in Saudi Arabia. Multiple Sclerosis J–Exper Transl Clin. 2020;6(4):2055217320960499.CrossRef
13.
go back to reference Harirchian MH, Fatehi F, Sarraf P, Honarvar NM, Bitarafan S. Worldwide prevalence of familial multiple sclerosis: a systematic review and meta-analysis. Multiple Scleros Related Disord. 2018;20:43–7.CrossRef Harirchian MH, Fatehi F, Sarraf P, Honarvar NM, Bitarafan S. Worldwide prevalence of familial multiple sclerosis: a systematic review and meta-analysis. Multiple Scleros Related Disord. 2018;20:43–7.CrossRef
14.
go back to reference Toghianifar N, Etemadifar M, Sharifzadeh A, Nasr Z. Characteristics of familial multiple sclerosis in Isfahan, Iran: a cross-sectional study. Neurol Asia. 2014;19(1):59–62. Toghianifar N, Etemadifar M, Sharifzadeh A, Nasr Z. Characteristics of familial multiple sclerosis in Isfahan, Iran: a cross-sectional study. Neurol Asia. 2014;19(1):59–62.
15.
go back to reference Ceccarelli A, Mifsud VA, Dogar A. Demographic and clinical characteristics of familial and sporadic multiple sclerosis: a single center exploratory study from Abu Dhabi. J Clin Neurosci. 2020;76:145–7.CrossRef Ceccarelli A, Mifsud VA, Dogar A. Demographic and clinical characteristics of familial and sporadic multiple sclerosis: a single center exploratory study from Abu Dhabi. J Clin Neurosci. 2020;76:145–7.CrossRef
16.
go back to reference Westerlind H, Ramanujam R, Uvehag D, Kuja-Halkola R, Boman M, Bottai M, et al. Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden. Brain J Neurol. 2014;137(3):770–8.CrossRef Westerlind H, Ramanujam R, Uvehag D, Kuja-Halkola R, Boman M, Bottai M, et al. Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden. Brain J Neurol. 2014;137(3):770–8.CrossRef
17.
go back to reference Steenhof M, Nielsen NM, Stenager E, Kyvik K, Möller S, Hertz JM. Distribution of disease courses in familial vs sporadic multiple sclerosis. Acta Neurol Scand. 2019;139(3):231–7.CrossRef Steenhof M, Nielsen NM, Stenager E, Kyvik K, Möller S, Hertz JM. Distribution of disease courses in familial vs sporadic multiple sclerosis. Acta Neurol Scand. 2019;139(3):231–7.CrossRef
18.
go back to reference Mahmudi L, Moslemirad M, Dabestani B, Shohani M, Azami M. Clinical and demographic features in Iranian multiple sclerosis patients: a systematic review and meta-analysis. Future Neurol. 2019;14(2):FNL19.CrossRef Mahmudi L, Moslemirad M, Dabestani B, Shohani M, Azami M. Clinical and demographic features in Iranian multiple sclerosis patients: a systematic review and meta-analysis. Future Neurol. 2019;14(2):FNL19.CrossRef
19.
go back to reference Hosseinzadeh A, Baneshi M, Sedighi B, Kermanchi J, Haghdoost A. Incidence of multiple sclerosis in Iran: a nationwide, population-based study. Public Health. 2019;175:138–44.CrossRef Hosseinzadeh A, Baneshi M, Sedighi B, Kermanchi J, Haghdoost A. Incidence of multiple sclerosis in Iran: a nationwide, population-based study. Public Health. 2019;175:138–44.CrossRef
20.
go back to reference Hosseinzadeh A, Baneshi MR, Sedighi B, Kermanchi J, Haghdoost AA. Geographic variations of multiple sclerosis in Iran: a population based study. Multiple Scleros Related Disord. 2019;28:244–9.CrossRef Hosseinzadeh A, Baneshi MR, Sedighi B, Kermanchi J, Haghdoost AA. Geographic variations of multiple sclerosis in Iran: a population based study. Multiple Scleros Related Disord. 2019;28:244–9.CrossRef
21.
go back to reference Moosazadeh M, Esmaeili R, Mehdi Nasehi M, Abedi G, Afshari M, Farshidi F, et al. Prevalence of familial multiple sclerosis in Iran: a systematic review and meta-analysis. Iran J Neurol. 2017;16(2):90–5.PubMedPubMedCentral Moosazadeh M, Esmaeili R, Mehdi Nasehi M, Abedi G, Afshari M, Farshidi F, et al. Prevalence of familial multiple sclerosis in Iran: a systematic review and meta-analysis. Iran J Neurol. 2017;16(2):90–5.PubMedPubMedCentral
22.
go back to reference Eskandarieh S, Allahabadi NS, Sadeghi M, Sahraian MA. Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999–2015. BMC Neurol. 2018;18(1):1–6.CrossRef Eskandarieh S, Allahabadi NS, Sadeghi M, Sahraian MA. Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999–2015. BMC Neurol. 2018;18(1):1–6.CrossRef
23.
go back to reference Shahin S, Eskandarieh S, Moghadasi AN, Razazian N, Baghbanian SM, Ashtari F, et al. Multiple sclerosis national registry system in Iran: validity and reliability of a minimum data set. Multiple Scleros Related Disord. 2019;33:158–61.CrossRef Shahin S, Eskandarieh S, Moghadasi AN, Razazian N, Baghbanian SM, Ashtari F, et al. Multiple sclerosis national registry system in Iran: validity and reliability of a minimum data set. Multiple Scleros Related Disord. 2019;33:158–61.CrossRef
24.
go back to reference Zipp F, Oh J, Fragoso YD, Waubant E. Implementing the 2017 McDonald criteria for the diagnosis of multiple sclerosis. Nat Rev Neurol. 2019;5(8):441–5. Zipp F, Oh J, Fragoso YD, Waubant E. Implementing the 2017 McDonald criteria for the diagnosis of multiple sclerosis. Nat Rev Neurol. 2019;5(8):441–5.
25.
go back to reference Krupp LB, Banwell B, Tenembaum S, International Pediatric MSSG. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007;68(16 Suppl 2):S7–12.CrossRef Krupp LB, Banwell B, Tenembaum S, International Pediatric MSSG. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007;68(16 Suppl 2):S7–12.CrossRef
26.
go back to reference Mirmosayyeb O, Brand S, Barzegar M, Afshari-Safavi A, Nehzat N, Shaygannejad V, et al. Clinical characteristics and disability progression of early-and late-onset multiple sclerosis compared to adult-onset multiple sclerosis. J Clin Med. 2020;9(5):1326.CrossRef Mirmosayyeb O, Brand S, Barzegar M, Afshari-Safavi A, Nehzat N, Shaygannejad V, et al. Clinical characteristics and disability progression of early-and late-onset multiple sclerosis compared to adult-onset multiple sclerosis. J Clin Med. 2020;9(5):1326.CrossRef
27.
go back to reference Pytel V, Matías-Guiu JA, Torre-Fuentes L, Montero P, Gómez-Graña Á, García-Ramos R, et al. Familial multiple sclerosis and association with other autoimmune diseases. Brain Behavior. 2018;8(1):e00899.CrossRef Pytel V, Matías-Guiu JA, Torre-Fuentes L, Montero P, Gómez-Graña Á, García-Ramos R, et al. Familial multiple sclerosis and association with other autoimmune diseases. Brain Behavior. 2018;8(1):e00899.CrossRef
28.
go back to reference Saadat M, Ansari-Lari M, Farhud D. Short report consanguineous marriage in Iran. Ann Hum Biol. 2004;31(2):263–9.CrossRef Saadat M, Ansari-Lari M, Farhud D. Short report consanguineous marriage in Iran. Ann Hum Biol. 2004;31(2):263–9.CrossRef
29.
go back to reference Patsopoulos NA. Genetics of multiple sclerosis: an overview and new directions. Cold Spring Harbor Perspect Med. 2018;8(7):a028951.CrossRef Patsopoulos NA. Genetics of multiple sclerosis: an overview and new directions. Cold Spring Harbor Perspect Med. 2018;8(7):a028951.CrossRef
30.
go back to reference Naser MA. Multiple sclerosis in parsis: a historical issue. Iran J Public Health. 2014;43(3):387–8. Naser MA. Multiple sclerosis in parsis: a historical issue. Iran J Public Health. 2014;43(3):387–8.
31.
go back to reference Dorche MS, Nikseresht A. The prevalence of familial multiple sclerosis in shiraz, southern Iran. Multiple Scleros Related Disord. 2020;37. Dorche MS, Nikseresht A. The prevalence of familial multiple sclerosis in shiraz, southern Iran. Multiple Scleros Related Disord. 2020;37.
32.
go back to reference Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F. Prevalence of multiple sclerosis in Isfahan, Iran. Neuroepidemiology. 2006;27(1):39–44. Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F. Prevalence of multiple sclerosis in Isfahan, Iran. Neuroepidemiology. 2006;27(1):39–44.
33.
go back to reference Ashtari F, Shaygannejad V, Heidari F, Akbari M. Prevalence of familial multiple sclerosis in Isfahan, Iran. J Isfahan Med School. 2011;29(138). Ashtari F, Shaygannejad V, Heidari F, Akbari M. Prevalence of familial multiple sclerosis in Isfahan, Iran. J Isfahan Med School. 2011;29(138).
34.
go back to reference Abedini M, Paksersht M, Rafiei A, Valadan R, Amjadi O, Khajavi R, et al. Demographic and clinical characteristics of multiple sclerosis. J Mazandaran Univ Med Sci. 2015;25(132):13–22 (Persian). Abedini M, Paksersht M, Rafiei A, Valadan R, Amjadi O, Khajavi R, et al. Demographic and clinical characteristics of multiple sclerosis. J Mazandaran Univ Med Sci. 2015;25(132):13–22 (Persian).
35.
go back to reference Taraghi Z, Ilali E, Abedini M, Zarvani A, Khoshnama I, Mohammadpour R, et al. Quality of life among multiple sclerosis patients. Iran J Nurs. 2007;20(50):51–9. Taraghi Z, Ilali E, Abedini M, Zarvani A, Khoshnama I, Mohammadpour R, et al. Quality of life among multiple sclerosis patients. Iran J Nurs. 2007;20(50):51–9.
36.
go back to reference Saman-Nezhad B, Rezaee T, Bostani A, Najafi F, Aghaei A. Epidemiological characteristics of patients with multiple sclerosis in Kermanshah, Iran in 2012. J Mazandaran Univ Med Sci. 2013;23(104):97–101. Saman-Nezhad B, Rezaee T, Bostani A, Najafi F, Aghaei A. Epidemiological characteristics of patients with multiple sclerosis in Kermanshah, Iran in 2012. J Mazandaran Univ Med Sci. 2013;23(104):97–101.
37.
go back to reference da Silva BM, Paiva CLA, Paradela ER, Alvarenga MP, Pereira FF, Vasconcelos CC, et al. Familial multiple sclerosis in a Brazilian sample: is HLA-DR15 involved in susceptibility to the disease? J Neuroimmunol. 2019;330:74–80.CrossRef da Silva BM, Paiva CLA, Paradela ER, Alvarenga MP, Pereira FF, Vasconcelos CC, et al. Familial multiple sclerosis in a Brazilian sample: is HLA-DR15 involved in susceptibility to the disease? J Neuroimmunol. 2019;330:74–80.CrossRef
38.
go back to reference Koch M, Zhao Y, Yee I, Guimond C, Kingwell E, Rieckmann P, et al. Disease onset in familial and sporadic primary progressive multiple sclerosis. Mult Scler J. 2010;16(6):694–700.CrossRef Koch M, Zhao Y, Yee I, Guimond C, Kingwell E, Rieckmann P, et al. Disease onset in familial and sporadic primary progressive multiple sclerosis. Mult Scler J. 2010;16(6):694–700.CrossRef
39.
go back to reference Rojas JI, Patrucco L, MIguez J, Sinay V, Cassara FP, Caceres F, et al. Disease onset in familial and sporadic multiple sclerosis in Argentina. Multiple Scleros Related Disord. 2016;6:54–6.CrossRef Rojas JI, Patrucco L, MIguez J, Sinay V, Cassara FP, Caceres F, et al. Disease onset in familial and sporadic multiple sclerosis in Argentina. Multiple Scleros Related Disord. 2016;6:54–6.CrossRef
40.
go back to reference Katsavos S, Artemiadis A, Davaki P, Stamboulis E, Kilindireas K, Anagnostouli M. Familial multiple sclerosis in Greece: distinct clinical and imaging characteristics in comparison with the sporadic disease. Clin Neurol Neurosurg. 2018;173:144–9.CrossRef Katsavos S, Artemiadis A, Davaki P, Stamboulis E, Kilindireas K, Anagnostouli M. Familial multiple sclerosis in Greece: distinct clinical and imaging characteristics in comparison with the sporadic disease. Clin Neurol Neurosurg. 2018;173:144–9.CrossRef
41.
go back to reference D'Amico E, Patti F, Zanghì A, Chisari C, Lo Fermo S, Zappia M. Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study. Eur J Neurol. 2018;25(12):1425–31.CrossRef D'Amico E, Patti F, Zanghì A, Chisari C, Lo Fermo S, Zappia M. Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study. Eur J Neurol. 2018;25(12):1425–31.CrossRef
42.
go back to reference Nielsen NM, Westergaard T, Rostgaard K, Frisch M, Hjalgrim H, Wohlfahrt J, et al. Familial risk of multiple sclerosis: a nationwide cohort study. Am J Epidemiol. 2005;162(8):774–8.CrossRef Nielsen NM, Westergaard T, Rostgaard K, Frisch M, Hjalgrim H, Wohlfahrt J, et al. Familial risk of multiple sclerosis: a nationwide cohort study. Am J Epidemiol. 2005;162(8):774–8.CrossRef
43.
go back to reference Romero-Pinel L, Martinez-Yelamos S, Gubieras L, Matas E, Bau L, Kremenchutzky M, et al. Anticipation of age at onset in familial multiple sclerosis. Eur J Neurol. 2010;17(4):572–5.CrossRef Romero-Pinel L, Martinez-Yelamos S, Gubieras L, Matas E, Bau L, Kremenchutzky M, et al. Anticipation of age at onset in familial multiple sclerosis. Eur J Neurol. 2010;17(4):572–5.CrossRef
44.
go back to reference Esposito F, Guaschino C, Sorosina M, Clarelli F, Mascia E, Santoro S, et al. Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction. Neurol-Neuroimmunol Neuroinflamm. 2015;9;2(4):e129. Esposito F, Guaschino C, Sorosina M, Clarelli F, Mascia E, Santoro S, et al. Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction. Neurol-Neuroimmunol Neuroinflamm. 2015;9;2(4):e129.
Metadata
Title
Epidemiology of familial multiple sclerosis in Iran: a national registry-based study
Authors
Zahra Salehi
Amir Almasi-Hashiani
Mohammad Ali Sahraian
Fereshteh Ashtari
Seyed Mohammad Baghbanian
Nazanin Razazian
Abdorreza Naser Moghadasi
Asghar Bayati
Amir Reza Azimi
Nahid Beladimoghadam
Mohammad Hossein Harirchian
Maryam Poursadeghfard
Samira Navardi
Reza Shirkoohi
Hora Heidari
Mehran Ghaffari
Sharareh Eskandarieh
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2022
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-022-02609-1

Other articles of this Issue 1/2022

BMC Neurology 1/2022 Go to the issue